Belimumab in Idiopathic Inflammatory Myositis

Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2015

Este artículo no está incluido en ninguna revisión sistemática

Cargando información sobre las referencias
The goal of the trial is to evaluate the efficacy and safety of belimumab as a maintenance therapy in adults with refractory Idiopathic inflammatory myositis (IIM) as compared with standard of care. This is a multicentre double-blind, placebo-controlled trial.
Epistemonikos ID: 9edd2d2869be5ee5d44e9c96464f0199cec1c3ba
First added on: May 12, 2024